Anti-integrin αv therapy improves cardiac fibrosis after myocardial infarction by blunting cardiac PW1+ stromal cells - UMS PASS - Production et analyse des données en sciences de la vie et en santé Accéder directement au contenu
Article Dans Une Revue Scientific Reports Année : 2020

Anti-integrin αv therapy improves cardiac fibrosis after myocardial infarction by blunting cardiac PW1+ stromal cells

Dan Skelly
  • Fonction : Auteur
Catherine Blanc
Nadia Rosenthal
  • Fonction : Auteur

Résumé

There is currently no therapy to limit the development of cardiac fibrosis and consequent heart failure. We have recently shown that cardiac fibrosis post-myocardial infarction (MI) can be regulated by resident cardiac cells with a fibrogenic signature and identified by the expression of PW1 (Peg3). Here we identify αV-integrin (CD51) as an essential regulator of cardiac PW1+ cells fibrogenic behavior. We used transcriptomic and proteomic approaches to identify specific cell-surface markers for cardiac PW1+ cells and found that αV-integrin (CD51) was expressed in almost all cardiac PW1+ cells (93% ± 1%), predominantly as the αVβ1 complex. αV-integrin is a subunit member of the integrin family of cell adhesion receptors and was found to activate complex of latent transforming growth factor beta (TGFβ at the surface of cardiac PW1+ cells. Pharmacological inhibition of αV-integrin reduced the profibrotic action of cardiac PW1+CD51+ cells and was associated with improved cardiac function and animal survival following MI coupled with a reduced infarct size and fibrotic lesion. These data identify a targetable pathway that regulates cardiac fibrosis in response to an ischemic injury and demonstrate that pharmacological inhibition of αV-integrin could reduce pathological outcomes following cardiac ischemia.
Fichier principal
Vignette du fichier
s41598-020-68223-8.pdf (6.95 Mo) Télécharger le fichier
Origine : Publication financée par une institution
Loading...

Dates et versions

hal-02899381 , version 1 (15-07-2020)

Identifiants

Citer

Marion Bouvet, Olivier Claude, Maguelonne Roux, Dan Skelly, Nihar Masurkar, et al.. Anti-integrin αv therapy improves cardiac fibrosis after myocardial infarction by blunting cardiac PW1+ stromal cells. Scientific Reports, 2020, 10 (1), pp.11404. ⟨10.1038/s41598-020-68223-8⟩. ⟨hal-02899381⟩
284 Consultations
66 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More